Royalty Pharma partners with J&J on $500M drug development deal
Go back to Royalty Pharma partners with J&J on $500M drug development deal| Johnson & Johnson (NYSE: JNJ) | Delayed: 235.26 +3.97 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $231.29 | 52 Week High | $126.07 | |||
| Open | $235.64 | 52 Week Low | $94.28 | |||
| Day High | $237.85 | P/E | 48.91 | |||
| Day Low | $234.35 | EPS | $4.81 | |||
| Volume | 2,461,831 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 54.66 +1.09 (2.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.57 | 52 Week High | $3.48 | |||
| Open | $53.58 | 52 Week Low | $0.80 | |||
| Day High | $54.68 | P/E | N/A | |||
| Day Low | $53.31 | EPS | $-1.54 | |||
| Volume | 1,076,942 | |||||
